Mical Paul

311 papers receiving 16.3k citations

Mical Paul's Hit Papers

Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed 2022 · 171 citations
1710+5+10Years since publication200400600

Peers

Mical Paul
Comparison fields: 5 of 178
  • Applied Microbiology and Biotechnology 1.6k
  • Molecular Medicine 3.3k
  • Clinical Biochemistry 1.7k
  • Critical Care and Intensive Care Medicine 719
  • Infectious Diseases 2.7k
Replace Leonard Leibovici with:
Leonard Leibovici Israel
Claudio Viscoli Italy
Matteo Bassetti Italy
Alan Forrest United States
Helen Giamarellou Greece
Cornelius J. Clancy United States
Michael B. Edmond United States
Winfried V. Kern Germany
Jordi Carratalà Spain
Keith S. Kaye United States
Mical Paul relative to Leonard Leibovici Israel Leonard Leibovici's profile →
Citations per field
00.5×1.6×
Leonard Leibovici · 1×
Citations per year

Countries citing papers authored by Mical Paul

Since Specialization
Citations

This map shows the geographic impact of Mical Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mical Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mical Paul more than expected).

Fields of papers citing papers by Mical Paul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mical Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mical Paul. The network helps show where Mical Paul may publish in the future.

Co-authors

The 25 scholars most cited alongside Mical Paul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mical Paul Line = papers co-authored together Mical Paul links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 321 papers — load more, or switch the sort, to bring in the rest.

#Work
1
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Hit paper breakdown →
2019676
2
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
Hit paper breakdown →
2010480
3
Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals
Hit paper breakdown →
2012347
4 2005345
5 2004305
6 2014291
7
Critical analysis of antibacterial agents in clinical development
Hit paper breakdown →
2020281
8 2010279
9 2007265
10 2012242
11 2013231
12 2014217
13 2009213
14 2011211
15 2007210
16 2011204
17 2020202
18 2008198
19 1997193
20 2013192

About Mical Paul

Mical Paul is a scholar working on Epidemiology, Molecular Medicine, Infectious Diseases, Clinical Biochemistry and Oncology, having authored 321 papers that have together received 16.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (58 papers), Bacterial Identification and Susceptibility Testing (42 papers), Antibiotic Use and Resistance (35 papers), Neutropenia and Cancer Infections (35 papers), Antibiotics Pharmacokinetics and Efficacy (30 papers), Pneumonia and Respiratory Infections (27 papers), Antimicrobial Resistance in Staphylococcus (20 papers) and Urinary Tract Infections Management (18 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.6k citations), Molecular Medicine (3.3k citations), Clinical Biochemistry (1.7k citations), Critical Care and Intensive Care Medicine (719 citations) and Infectious Diseases (2.7k citations). Mical Paul has collaborated with scholars based in Israel, Italy and United Kingdom. Frequent co-authors include Leonard Leibovici, Dafna Yahav, Anat Gafter‐Gvili, Abigail Fraser, Liat Vidal, Tomer Avni, Hefziba Green, Adi Lador, Elad Goldberg and Eyal Robenshtok. Their work appears in journals such as Clinical Microbiology and Infection, Cochrane Database of Systematic Reviews, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact